Skip to main content

Fatty liver disease is a major untapped opportunity for nutraceuticals; platform established

Research, focus and regulatory cunning will be needed if the nutraceutical industry is to tap into the relatively unexplored area of non-alcoholic fatty liver disease (NAFLD), says the consultancy firm behind a new dedicated clinical trial platform.



from NutraIngredients RSS http://ift.tt/1GICI37
via IFTTT

Popular posts from this blog

Hany Rambod's Ultimate Guide To FST-7

What do the bodybuilding greats of our time all have in common? A style of training that showed them the limitless potential of their physique. Here's what you need to know about FST-7. Hany Rambod's nickname is "The Pro Creator." He's watched his protégés take home the ultimate prize at the Olympia Weekend 15 times—including three on a single night in 2014. Far more times than that, he's watched his clients push their already impressive physiques where they never thought possible. The way he did it is no mystery. Rambod's clients all followed FST-7, or "fascia-stretch training," his signature training style. Do it right, and it can substantially change both the size and shape of your muscles. Just don't expect it to be easy or painless. If you've wondered what all the fuss is about, Rambod has created a video explaining the fundamentals of FST-7, along with tips on how to scale it for everyone from beginners to advanced lifters and h